Evidence map›Paper›PMID 40069947›Full record

ArticleAmerican journal of epidemiology2026

Hepatitis C virus transmission among people who inject drugs in rural United States: mathematical modeling study using stochastic agent-based network simulation.

Lin Zhu, Jennifer R Havens, Abby E Rudolph, April M Young, Golnaz Eftekhari Yazdi, William W Thompson, Liesl M Hagan, Liisa M Randall, Jianing Wang, Rebecca Earnest and 3 more

Abstract read
In one paragraph

Article in American journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lin ZhuDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, United States.ORCID 0000-0002-4490-9246
Jennifer R HavensCenter on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington, KY, United States.ORCID 0000-0002-1753-7280
Abby E RudolphDepartment of Epidemiology and Biostatistics, Temple University College of Public Health, Philadelphia, PA, United States.ORCID 0000-0003-1786-3307
April M YoungCenter on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington, KY, United States.ORCID 0000-0003-3969-3249
Golnaz Eftekhari YazdiSection of Infectious Disease, Department of Medicine, Boston Medical Center, Boston, MA, United States.
William W ThompsonPrevention Branch, Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0001-8293-9641
Liesl M HaganPrevention Branch, Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0001-5466-6893
Liisa M RandallBureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Boston, MA, United States.
Jianing WangSection of Infectious Disease, Department of Medicine, Boston Medical Center, Boston, MA, United States.ORCID 0000-0003-4709-3091
Rebecca EarnestDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, United States.ORCID 0000-0001-6555-8409
Shayla NolenSection of Infectious Disease, Department of Medicine, Boston Medical Center, Boston, MA, United States.ORCID 0000-0002-1740-7435
Benjamin P LinasSection of Infectious Disease, Department of Medicine, Boston Medical Center, Boston, MA, United States.ORCID 0000-0001-9574-7075
Joshua A SalomonDepartment of Health Policy, School of Medicine, Stanford University, Stanford, CA, United States.ORCID 0000-0003-3929-5515

Funding

Examining the Impact of the Twin Epidemics of Methamphetamine and Opioid Use on Overdose, Risky Sex and Treatment Engagement among PWUD in Two Rural Appalachian CohortsR01DA033862 · NIDA · UNIVERSITY OF KENTUCKY · PI Jennifer R Havens · 2012 to 2026
$6.9M
Making Better Decisions: Policy Modeling for AIDS and Drug AbuseR37DA015612 · NIDA · STANFORD UNIVERSITY · PI DOUGLAS K OWENS · 2019 to 2026
$6.3M
Social networks and HIV risk among rural drug usersR01DA024598 · NIDA · UNIVERSITY OF KENTUCKY · PI HAVENS, JENNIFER R · 2008 to 2012
$2.6M
Prospects for hepatitis C elimination in networks of people who inject drugs through improvements in the care continuumK99DA056297 · NIDA · STANFORD UNIVERSITY · PI ZHU, LIN · 2023 to 2024
$357k
NIDA NIH HHS K99 DA056297NIDA NIH HHS K99DA056297, R37DA015612, R01DA033862, R01DA024598NIDA NIH HHS R01 DA024598NIDA NIH HHS R01 DA033862NIDA NIH HHS R37 DA015612US Centers for Disease Control and Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention Epidemiologic and Economic Modeling Agreement U38PS004644, NU38PS004651
6 · The paper itself

Abstract

People who inject drugs (PWID) account for the majority of hepatitis C virus (HCV) infections in the United States. The injection-equipment-sharing network likely plays an important role in shaping the dynamics of HCV transmission. Recognizing the emerging HCV epidemic in rural communities, we developed an agent-based network simulation model of HCV transmission via injection equipment sharing and used data on rural PWID networks to inform model parameterization and calibration. We then simulated an array of networks that varied key network properties to understand their impact on the magnitude and distribution of HCV incidence. The results show substantial heterogeneity in HCV acquisition risks across the network, summarized using the Gini coefficient. In addition, although PWID with fewer injection partners had lower incidence, they collectively acquired more infections due to their larger population size. Higher prevalence, average number of partners, and homophily in HCV infection were associated with lower heterogeneity in infection risk across the network and higher overall incidence; other network properties including population size did not have a substantial impact. Our findings illustrate the heterogeneity of HCV transmission among PWID and suggest key network properties that could be measured, evaluated, or considered in the design of interventions for PWID in future studies.

Indexed as

Hepatitis CNeedle SharingRural PopulationSubstance Abuse, IntravenousComputer SimulationHumansIncidenceMaleModels, TheoreticalPrevalenceStochastic ProcessesUnited Stateshepatitis Cheterogeneitypeople who inject drugsrural populationsimulation modelsocial networktransmission

Identifiers

PMID40069947
PMCPMC13066326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.